DUBLIN, Ireland--(BUSINESS WIRE)--Jan. 12, 2005--Elan Corporation, plc today announced that its proprietary NanoCrystal(R) technology is being used by Johnson & Johnson Pharmaceutical Research & ...

Elan Drug Technologies (EDT), the drug delivery unit of Elan Corporation, plc (NYSE: ELN), today announced that the first injectable product using EDT's NanoCrystal® technology has been approved by ...

Elan Pharma International Ltd., a subsidiary of Elan Corporation plc, today announced an agreement to license its proprietary NanoCrystal technology to Roche. NanoCrystal technology can improve the ...

Elan Drug Technologies, a business unit of Elan Corporation, plc (NYSE: ELN) announces the first approval of a long-acting injectable formulation using Elan Drug Technologies’ proprietary NanoCrystal ...

Theravance, Inc. and Elan Corporation, plc announced that they have entered into a royalty participation agreement wherein Elan will purchase a participation interest in potential future royalty ...

DENVER, CO — CEDIA Booth #610 — ELAN Home Systems, a leading manufacturer of award-winning Multi-room audio/video and home control systems, announced today that the company will utilize the ...

Alkermes said Monday it has made an agreement with Elan Corporation to acquire its drug formulation and manufacturing business in a cash and stock transaction valued at $960 million. The two entities ...